Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer-Reference-Cited by-同舟云学术

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

Published:2014-07 Issue:7 Volume:25 Page:1346-1355
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Douillard J.Y.,Siena S.,Cassidy J.,Tabernero J.,Burkes R.,Barugel M.,Humblet Y.,Bodoky G.,Cunningham D.,Jassem J.,Rivera F.,Kocákova I.,Ruff P.,Błasińska-Morawiec M.,Šmakal M.,Canon J.L.,Rother M.,Oliner K.S.,Tian Y.,Xu F.,Sidhu R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/25/7/1346/19446814/mdu141.pdf

Reference24 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;Amado;J Clin Oncol,2008

3. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study;Douillard;J Clin Oncol,2010

4. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer;Peeters;J Clin Oncol,2010

5. KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab;De Roock;Ann Oncol,2008

Cited by 475 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of HER2-targeted therapy and strategies to overcome the drug resistance in colorectal cancer;Biomedicine & Pharmacotherapy;2024-10

2. Hazard Ratios and Alternative Effect Measures: An Applied Illustration;Pharmacoepidemiology and Drug Safety;2024-08-30

3. From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies;International Journal of Molecular Sciences;2024-08-30

4. EGFR mutations and abnormal trafficking in cancers;Molecular Biology Reports;2024-08-21

5. Advances in Personalized Oncology;Cancers;2024-08-16